Home / Sitagliptin / Czechia
CZ ATC A10BH01 · updated 2 Nov 2026
Sitagliptin shortage in Czechia
Is there a Sitagliptin shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Sitagliptin product is reported short in Czechia. The company estimate for the return is 1 Jan 2028. Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Ireland, Austria, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SITAGLIPTIN GLENMARK 100MG 100MG TBL FLM 98 anticipated | Glenmark Pharmaceuticals s.r.o., Praha | 9 Nov 2026 | 1 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.